Cite

HARVARD Citation

    Paralta Branco, F. et al. (n.d.). Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer. European journal of cancer. pp. S94-. [Online]. 
  
Back to record